Trump’s Executive Order Expediting Ibogaine Research: A Historic Move for Mental Health
President Trump signed an executive order directing the FDA to expedite the review of ibogaine and other psychedelics aimed at treating mental health disorders.
President Trump signed an executive order directing the FDA to expedite the review of ibogaine and other psychedelics aimed at treating mental health disorders.
Trump’s latest executive order reschedules cannabis, marking a historic moment for cannabis reform. Learn what this means for the industry today.
The White House has announced a new executive order for prosecuting desecration of the American flag, emphasizing national unity and security.